05 February 2019
"Effective enforcement of EU competition rules in the pharmaceutical law remains a matter of high priority…"
www.twobirds.com/en/news/articles/2019/global/effective-enforcement-of-eu-competition-rules-in-pharmaceutical-law

So notes the Commission's report on competition enforcement in the pharmaceutical sector (2009-2017) published at the end of January 2019.

08 May 2019
Manufacturing and stockpiling waiver set to limit rights of holders of SPCs for medicines
www.twobirds.com/en/news/articles/2019/global/manufacturing-and-stockpiling-waiver-set-to-limit-rights-of-holders-of-spcs-for-medicines

On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").

22 November 2019
Access to toxicity study reports and protection of commercial interests
www.twobirds.com/en/news/articles/2019/uk/access-to-toxicity-study-reports-and-protection-of-commercial-interests

Gerard Hogan, Advocate General at the Court of Justice of the European Union (“CJEU”) recently delivered an opinion in the pending case between MSD Animal Health Innovation (“MSD”), Intervet international (“Intervet”) ...

02 July 2019
Transfer of value: amendments to the French “anti-gift” provisions by the draft Health Act
www.twobirds.com/en/news/articles/2019/global/transfer-of-value-amendments-to-the-french-anti-gift-provisions-by-the-draft-health-act

The French so-called “anti-gift” provisions strictly frame the conditions under which companies in the health sector are allowed to provide advantages, in cash or in kind, to healthcare professionals ("HCPs”)

02 December 2019
The French Health Data Hub becomes reality
www.twobirds.com/en/news/articles/2019/france/the-french-health-data-hub-becomes-reality

The French Health Data Hub was born officially with the publication on 30 November 2019 of a ministerial decision (arrêté).

15 November 2018
Supreme Court defines plausibility in the context of sufficiency
www.twobirds.com/en/news/articles/2018/uk/supreme-court-defines-plausibility-in-the-context-of-sufficiency

A majority postulates a new "outward presentation test" to deal with the infringement of second medical use patents.

30 September 2019
Bird & Bird secures win in preliminary injunction patent case before the Düsseldorf Courts
www.twobirds.com/en/news/articles/2019/germany/bird-and-bird-secures-win-in-preliminary-injunction-patent-case-before-the-dusseldorf-courts

On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against ...

01 June 2020
Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB
www.twobirds.com/en/news/press-releases/2020/czech-republic/bird-and-bird-law-firm-advised-indian-vaccine-manufacturer-serum-institute-of-india-pvt-ltd

Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB, subsidiary of Novavax Inc, US ...

24 May 2019
Can CRISPR save the Cavendish?
www.twobirds.com/en/news/articles/2019/global/can-crispr-save-the-cavendish

The world's most popular banana is dying. Scientists are using the gene-editing mechanism CRISPR to try and save it from extinction.

13 May 2020
Bird & Bird advised Materia on its acquisition of German licensed medicinal cannabis distributor Cannaktiv
www.twobirds.com/en/news/press-releases/2020/germany/bird-beraet-materia-beim-erwerb-von-cannaktiv

Bird & Bird LLP advised Materia on the acquisition of all shares in German licensed medicinal cannabis distributor Cannaktiv GmbH. The deal provides Materia – an international manufacturer and distributor of medicinal ...